Item

Vaccines and the Prisoners Dilemma

Title (Dublin Core)

Vaccines and the Prisoners Dilemma
Les Vaccins et Le Dilemme du Prisonnier

Description (Dublin Core)

This article explains how rich countries are creating inequality access to Covid-19 vaccines. For example, a report by Oxfam warns that "the rich nations represent only 13% of the global population have already acquired 51% of planned doses of the most promising candidate vaccines."
Cet article explique comment les pays riches font un accès inégal aux vaccins Covid-19. Par exemple, un rapport d’Oxfam avertissait que « des nations riches représentant seulement 13 % de la population mondiale ont déjà acquis 51 % des doses prévues des candidats-vaccins contre la COVID-19 les plus prometteurs »
Translation of graphic: 500 doses* United Kingdom, 11 doses* Bangladesh, 940 doses * Canada *per 100 inhabitants

Date (Dublin Core)

October 24, 2020

Creator (Dublin Core)

Julien Lamoureux

Contributor (Dublin Core)

Britton McNerlin

Event Identifier (Dublin Core)

HSE

Partner (Dublin Core)

Arizona State University

Type (Dublin Core)

Screenshot, Link

Link (Bibliographic Ontology)

Controlled Vocabulary (Dublin Core)

English Business & Industry
English Government Federal
English News coverage
English Social Class

Curator's Tags (Omeka Classic)

wealthy nation
broken system
monopoly
WHO
Vaccine Alliance
shortage
nationalism

Contributor's Tags (a true folksonomy) (Friend of a Friend)

Canada
Quebec
French
vaccine
geopolitics
health
government
inequality

Collection (Dublin Core)

Canada
Vaccine Stories

Linked Data (Dublin Core)

Date Submitted (Dublin Core)

10/27/2020

Date Modified (Dublin Core)

02/20/2021
3/12/2021
03/31/2021
05/05/2022

Date Created (Dublin Core)

10/24/2020

Item sets

This item was submitted on October 27, 2020 by Britton McNerlin using the form “Share Your Story” on the site “A Journal of the Plague Year”: https://covid-19archive.org/s/archive

Click here to view the collected data.

New Tags

I recognize that my tagging suggestions may be rejected by site curators. I agree with terms of use and I accept to free my contribution under the licence CC BY-SA